Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 65841-639

1 FDA label image from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 65841-639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

27ab558b E2e6 4720 A700 63633efbfb76 05

27ab558b E2e6 4720 A700 63633efbfb76 05
Label for Divalproex Sodium Delayed-Release Capsules USP (Sprinkle) 125 mg, coated pellets in capsule form. The label indicates a package of 100 capsules, labeled for oral use, and produced by Zydus Lifesciences Limited. It includes dosage information, storage instructions, and a barcode. The label also shows the capsule's color and markings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.